USA
Showing 17–20 of 20 results
-
FDA Guidance: Types of Communication During the Review of Medical Device Submission (2014)
$0.00 Add to cart -
FDA: Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency
$2.00 Add to cart -
FDA: Post-marketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic
$2.00 Add to cart -
US FDA Guidance: Best Practices in Developing Proprietary Names for Human Prescription Drug Products
$5.00 Add to cart